We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UFS
201
DELISTED
DOMTAR CORPORATION (New)
UFS
| $7.49M | 0.13% |
201,701
+98,660
| +96% | +$3.63M |
|
202
Exelon
EXC
$48.8B
| $7.47M | 0.13% |
314,791
-198,677
| -39% | -$4.99M |
|
|
ABCO
203
DELISTED
Advisory Board Co
ABCO
| $7.45M | 0.13% |
166,438
+21,910
| +15% | +$901K |
|
204
M&T Bank
MTB
$35.8B
| $7.22M | 0.13% |
62,186
+14,900
| +32% | +$1.73M |
|
205
Regency Centers
REG
$15B
| $7.21M | 0.13% |
93,095
-2,220
| -2% | -$179K |
|
|
PGRE
206
DELISTED
Paramount Group
PGRE
| $7.18M | 0.13% |
438,003
+92,220
| +27% | +$1.58M |
|
|
207
Global Payments
GPN
$21.7B
| $7.03M | 0.13% |
91,625
-321,517
| -78% | -$24.2M |
|
|
CHK
208
DELISTED
Chesapeake Energy Corporation
CHK
| $7.01M | 0.13% |
5,587
+570
| +11% | +$657K |
|
209
Comcast
CMCSA
$79.6B
| $6.97M | 0.12% |
210,012
-185,900
| -47% | -$6.19M |
|
|
INFN
210
DELISTED
Infinera Corporation Common Stock
INFN
| $6.91M | 0.12% |
765,100
+100,669
| +15% | +$973K |
|
211
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $6.88M | 0.12% |
31,800
-20,000
| -39% | -$4.32M |
|
212
RingCentral
RNG
$3.95B
| $6.82M | 0.12% |
288,242
+74,052
| +35% | +$1.67M |
|
213
Affiliated Managers Group
AMG
$9.24B
| $6.8M | 0.12% |
46,982
+44,062
| +1,509% | +$6.31M |
|
|
MDRX
214
DELISTED
Veradigm Inc. Common Stock
MDRX
| $6.79M | 0.12% |
515,568
+182,268
| +55% | +$2.44M |
|
215
HUB Group
HUBG
$2.97B
| $6.78M | 0.12% |
332,640
+54,000
| +19% | +$1.1M |
|
|
CVSA
216
Covista Inc
CVSA
$3.9B
| $6.77M | 0.12% |
293,630
-12,374
| -4% | -$276K |
|
217
Factset
FDS
$8.84B
| $6.67M | 0.12% |
+41,181
| New | +$7.1M |
|
218
Brinker International
EAT
$7.92B
| $6.67M | 0.12% |
132,280
-119,016
| -47% | -$5.99M |
|
219
Southern Company
SO
$110B
| $6.67M | 0.12% |
129,980
+71,450
| +122% | +$3.76M |
|
|
ENH
220
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $6.66M | 0.12% |
101,724
-52,790
| -34% | -$3.5M |
|
221
AptarGroup
ATR
$8.36B
| $6.61M | 0.12% |
85,410
+41,025
| +92% | +$3.21M |
|
222
Unisys
UIS
$230M
| $6.49M | 0.12% |
666,753
+132,090
| +25% | +$1.23M |
|
|
NAV
223
DELISTED
Navistar International
NAV
| $6.33M | 0.11% |
276,342
-128,940
| -32% | -$1.96M |
|
|
AEL
224
DELISTED
American Equity Investment Life Holding Company
AEL
| $6.31M | 0.11% |
355,682
+53,130
| +18% | +$877K |
|
225
Adtran
ADTN
$798M
| $6.29M | 0.11% |
328,809
-900
| -0.3% | -$16.6K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.